Lise Lotte Hansen

Comprehensive genome methylation analysis in bladder cancer;identification and validation of novel methylated genes and application of these as urinary tumor markers

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

PURPOSE: Epigenetic alterations are common and can now be addressed in a parallel fashion. We investigated the methylation in bladder cancer with respect to location in genome, consistency, variation in metachronous tumors, impact on transcripts, chromosomal location, and usefulness as urinary markers.EXPERIMENTAL DESIGN: A microarray assay was utilized to analyze methylation in 56 samples. Independent validation was performed in 63 samples by a PCR based method and bisulfite sequencing. The methylation levels in 174 urine specimens were quantified. Transcript levels were analyzed using expression microarrays, and pathways using dedicated software. RESULTS: Global methylation patterns were established within and outside CpG-islands. We validated methylation of the eight tumor markers genes ZNF154 (p
Original languageEnglish
JournalClinical Cancer Research
ISSN1078-0432
DOIs
Publication statusPublished - 25 Jul 2011

See relations at Aarhus University Citationformats

Press/Media items

ID: 39892962